Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 2

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Weekly Wrap 23 June

Grady Wulff
June 23, 2023

Morning Bell 23 June

Sophia Mavridis
June 23, 2023

Morning Bell 22 June

Sophia Mavridis
June 22, 2023

Morning Bell 21 June

Grady Wulff
June 21, 2023

Morning Bell 20 June

Grady Wulff
June 20, 2023

Morning Bell 19 June

Grady Wulff
June 19, 2023

Weekly Wrap 16 June

Grady Wulff
June 16, 2023

Morning Bell 15 June

Grady Wulff
June 15, 2023

Morning Bell 14 June

Grady Wulff
June 14, 2023

Morning Bell 13 June

Sophia Mavridis
June 13, 2023

Weekly Wrap 9 June

Sophia Mavridis
June 9, 2023

Morning Bell 8 June

Grady Wulff
June 8, 2023